Anti-Alpha-synuclein antibody [LB 509] (ab27766) is a mouse monoclonal antibody detecting Alpha-synuclein in Western Blot, Flow Cytometry (Intra), Flow Cytometry. Suitable for Human, Rat,.
- Over 80 publications
- Trusted since 2006
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: PBS, 6.97% L-Arginine
Flow Cyt (Intra) | WB | |
---|---|---|
Human | Expected | Tested |
Rat | Tested | Expected |
Purified native protein - Human | Not recommended | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info 1 µg for 106 Cells | Notes Mouse IgG1, kappa monoclonal [15-6E10A7] - Isotype Control ab170190 - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Purified native protein - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Purified native protein - Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes - |
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Select an associated product type
The protein expressed by the SNCA gene is involved in various synaptic activities, including the regulation of synaptic vesicle trafficking and neurotransmitter release. As a monomer, it enhances synaptic vesicle exocytosis through vesicle priming, fusion, and dilation of exocytotic fusion pores. Mechanistically, it increases local Ca(2+) release, which is crucial for ATP-induced exocytosis. In its multimeric membrane-bound form, SNCA acts as a molecular chaperone, assisting in the folding of synaptic fusion components known as SNAREs at the presynaptic plasma membrane, in conjunction with cysteine string protein-alpha/DNAJC5, a function that is vital for maintaining normal SNARE-complex assembly during aging. Additionally, SNCA plays a role in dopamine neurotransmission regulation by associating with the dopamine transporter (DAT1) and modulating its activity. This supplementary information is collated from multiple sources and compiled automatically.
NACP, PARK1, SNCA, Alpha-synuclein, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor
Anti-Alpha-synuclein antibody [LB 509] (ab27766) is a mouse monoclonal antibody detecting Alpha-synuclein in Western Blot, Flow Cytometry (Intra), Flow Cytometry. Suitable for Human, Rat,.
- Over 80 publications
- Trusted since 2006
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: PBS, 6.97% L-Arginine
Anti-Alpha-synuclein antibody [LB 509] (ab27766) is a mouse monoclonal antibody and is validated for use in Flow Cyt (Intra), Western Blot in human, mouse, rat samples.
Anti-Alpha-synuclein antibody [LB 509] (ab27766) has been cited over 81 times in peer reviewed journals and is trusted by the scientific community.
Abcam's high quality validation processes ensure Anti-Alpha-synuclein antibody [LB 509] (Anti-SNCA antibody) (ab27766) has high sensitivity and specificity.
Anti-Alpha-synuclein antibody [LB 509] (ab27766) has 12 independent reviews from customers.
Anti-Alpha-synuclein antibody [LB 509] (ab27766) specifically detects Alpha-synuclein (UniProt ID: P37840; Molecular weight: 14kDa) and is sold in 100 µg selling sizes.
Synuclein Alpha (SNCA) is a protein primarily found in the brain, where it plays a crucial role in the regulation of synaptic vesicle trafficking and neurotransmitter release. It is a key component of Lewy bodies, which are pathological hallmarks of Parkinson's disease. Mutations and abnormal aggregation of SNCA are linked to several neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Alpha-synuclein is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals. The deposition of the abundant presynaptic brain protein alpha-synuclein as fibrillary aggregates in neurons or glial cells is a hallmark lesion in a subset of neurodegenerative disorders. These disorders include Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy, collectively referred to as synucleinopathies. Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Alpha-synuclein often referred to by alternate names such as SNCA is a protein of around 14 kDa mass. It mainly expresses in the brain particularly in presynaptic nerve terminals. This protein functions mechanically by stabilizing synaptic vesicles and maintaining synaptic function. It exists both in soluble monomer forms and as aggregates in protein filaments. Antibodies like 4D6 and EP1536Y target monomer forms of protein for more detailed studies.
The alpha-synuclein protein plays critical roles in neuronal activity. It contributes to neurotransmitter release regulation by acting in the formation and plasticity of the presynaptic neuronal network. Alpha-synuclein doesn't usually form parts of large protein complexes but it may associate transiently with membranes and vesicular structures. The protein's monomer form has also been observed in alpha lines and related neuronal processes operating alongside various cellular functions.
Synaptic vesicle trafficking and dopamine neurotransmitter release are significant areas involving the alpha-synuclein protein. In these pathways alpha-synuclein interacts with other proteins like synaptophysin and protein monomer monomerizations are intrinsic to these processes. Altered function or aggregation of alpha-synuclein disrupts these pathways influencing broader neurological functions.
Alterations or accumulations of alpha-synuclein are strongly linked to Parkinson's disease and Lewy body dementia. In these conditions alpha-synuclein forms abnormal protein filaments known as Lewy bodies within neurons. These formations disrupt cellular processes and neuron health. Synucleinopathies such as these show connections with proteins like parkin and DJ-1 which also have key roles in these neurodegenerative diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-Alpha-synuclein antibody [LB 509] (ab27766) at 1/1000 dilution
All lanes: Western blot - Recombinant Human Alpha-synuclein protein (Recombinant Human Alpha-synuclein protein ab51189) at 0.1 µg
All lanes: Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 14 kDa
Exposure time: 8min
Overlay histogram showing PC12 (NGF differentiated) cells stained with ab27766 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (ab27766, 1μg/1x106) for 30 min at 22°C. The secondary antibody used was Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed (Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed ab150117) at 1/2000 dilution for 30 min at 22°C.
Isotype control antibody (black line) was Mouse IgG1 [15-6E10A7] (Mouse IgG1, kappa monoclonal [15-6E10A7] - Isotype Control ab170190) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5,000 events were collected using a 50mW Blue laser (488nm) and 530/30 bandpass filter.
All lanes: Western blot - Anti-Alpha-synuclein antibody [LB 509] (ab27766) at 5 µg/mL
Lane 1: Western blot - Recombinant Human Alpha-synuclein protein (Recombinant Human Alpha-synuclein protein ab51189) at 10 µg
Lane 2: Human brain hippocampus tissue lysate - total protein (ab30180) at 10 µg
All lanes: Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 14 kDa
Observed band size: 16 kDa, 32 kDa
Exposure time: 20min
All lanes: Western blot - Anti-Alpha-synuclein antibody [LB 509] (ab27766) at 1/1000 dilution
All lanes: Western blot - Recombinant Human Alpha-synuclein protein (Recombinant Human Alpha-synuclein protein ab51189) at 0.1 µg
All lanes: Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) at 5000 µg
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 14 kDa
Exposure time: 8min
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com